DIA
Drug Information Association Logo

DIA 2014 50th Annual Meeting to Highlight New IMI Collaborative Initiative

WASHINGTON — mar 31, 2014

GetReal project seeks practical solutions for integrating real-world data to better inform the drug development process

GetReal, a collaborative project recently launched by the European Union’s Innovative Medicines Initiative (IMI), will be highlighted at the DIA 2014 50th Annual Meeting taking place June 15 to 19 at the San Diego Convention Center. The forum discussion—How Can Studies That Inform Relative Effectiveness Best Be Incorporated Into Global Drug Development Plans?—will be held June 19 at 10:45 a.m.

As Europe’s largest public-private partnership, IMI seeks to create better and safer medicines for patients by supporting more effective discovery of information in the drug development process. The GetReal project connects health technology assessment agencies, industry and regulatory bodies with academia, subject matter and patient group experts to enhance this discovery process by better understanding how real-world data and analytical techniques can inform and improve drug development.

“Our annual meeting is a global platform to facilitate innovation that will change the future of health care,” said Barbara L. Kunz, DIA global chief executive. “The GetReal project exemplifies the collaboration needed to bring safer and better products to patients around the world.”

Incorporating data from real-world clinical settings into drug development and associated decision-making represents a serious challenge for pharmaceutical companies, regulators and health authorities; the GetReal project unites these key stakeholders to develop new approaches and greater consensus. The DIA forum will focus specifically on the challenges in implementing alternative drug development strategies prior to medicine authorization, and explain how global drug development plans can better incorporate relative effectiveness objectives, real-world data and analytical techniques prior to this authorization.

 



Contact: Tiffany Cohen
+1.202.499.4411
tcohen@reingold.com


###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.
 
ABOUT DIA’s 2014 50th ANNUAL MEETING: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products. The meeting aims to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. For more information, visit www.diahome.org/dia2014.